Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Valuation
P/E Ratio
25.00x
Forward P/E
16.25x
EPS
17.71
PEG Ratio
—
P/B Ratio
7.22x
Beta
0.58
Profitability
Revenue Growth
0.20%
Earnings Growth
33.90%
Gross Margin
67.87%
Operating Margin
26.27%
Net Margin
14.30%
Return on Equity
27.26%
Return on Assets
9.85%
Financial Health
Debt / Equity
1.82x
Current Ratio
1.30x
Quick Ratio
0.76x
Free Cash Flow
3.5B
Dividends
Dividend Yield
5.19%
Payout Ratio
129.94%
Ex-Dividend Date
2025-12-05
Source: Yahoo Finance
Price Target
Low
DKK 400.00
Average
DKK 566.68
High
DKK 760.00
Source: Yahoo Finance
No recent press releases found